发明名称 Method for determining predisposition to pulmonary infection
摘要 Provided herein are methods and materials for diagnosing a subject's predisposition for pulmonary infection in a CF subject by detecting a pulmonary infection genetic marker. Pulmonary infection markers have been identified in the IL-1 gene cluster and may be useful in predicting CF disease progression and assessing a CF subject's response to therapy.
申请公布号 US9133518(B2) 申请公布日期 2015.09.15
申请号 US201113296557 申请日期 2011.11.15
申请人 Presidental and Fellows of Harvard College 发明人 Levy Hara;Gerard Craig;Pier Gerald;Weiss Scott;Lange Christoph
分类号 C12P19/34;C12Q1/68;A61K38/14 主分类号 C12P19/34
代理机构 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. 代理人 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Corless Peter F.;Cowles Christopher R.
主权项 1. A method of treating a pulmonary infection in a human subject with a pulmonary infection marker, comprising: detecting a pulmonary infection marker in a sample from the subject, wherein the detection of the marker comprises: (a) providing a nucleic acid-containing sample obtained from the subject;(b) amplifying a nucleic acid comprising the marker; and(c) detecting the amplified nucleic acids, thereby detecting the marker, wherein the pulmonary infection marker is selected from the group consisting of SEQ ID NO:3, SEQ ID NO:1, SEQ ID NO:5, SEQ ID NO:7 and SEQ ID NO:15; and administering an anti-inflammatory agent or antibacterial agent to the subject in which the pulmonary infection marker is detected, thereby treating the pulmonary infection in the subject.
地址 Cambridge MA US